Bridging the gap between academic research and regulatory health risk assessment of Endocrine Disrupting Chemicals
Tóm tắt
Từ khóa
Tài liệu tham khảo
European Chemicals Agency (ECHA), 2012
European Food Safety Authority (EFSA), 2010, Guidance of EFSA Application of systematic review methodology to food and feed safety assessments to support decision making, EFSA J, 8, 90
US National Research Council of the National, 2014
Organisation for Economic Co-operation Development (OECD), 2005
United Stated Environmental Protection Agency, 2014
Kortenkamp, 2012
Myers, 2009, Why public health agencies cannot depend on good laboratory practices as a criterion for selecting data: the case of bisphenol A, Environ Health Perspect, 117, 309, 10.1289/ehp.0800173
United Nations Environment Programme the World Health Organization, 2012
Zoeller, 2012, Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society, Endocrinology, 153, 4097, 10.1210/en.2012-1422
European Food Safety Authority, 2013
Schug, 2013, Designing endocrine disruption out of the next generation of chemicals, Green Chem, 15, 181, 10.1039/C2GC35055F
European Environment Agency, 2012
Parliament:, 2013
Organisation for Economic Co-operation and Development (OECD). Detailed Review Paper on the State of the Science on novel in vitro and in vivo screening and testing methods and endpoints for evaluating endocrine disruptors. Series on Testing & Assessment No. 178. 2012:. Available online at: http://www.oecd.org/chemicalsafety/testing/seriesontestingandassessmenttestingforendocrinedisrupters.htm.
Juberg, 2014, t4 workshop report--lessons learned, challenges, and opportunities: the U.S. Endocrine Disruptor Screening Program, ALTEX, 31, 63, 10.14573/altex.1309171
Beronius, 2013, The influence of study design and sex-differences on results from developmental neurotoxicity studies of bisphenol A, implications for toxicity testing, Toxicology, 311, 13, 10.1016/j.tox.2013.02.012
Schug, 2013, A new approach to synergize academic and guideline-compliant research: the CLARITY-BPA research program, Reprod Toxicol, 40, 35, 10.1016/j.reprotox.2013.05.010
Alcock, 2011, Understanding the mismatch between the demands of risk assessment and practice of scientists—the case of Deca-BDE, Environ Int, 37, 216, 10.1016/j.envint.2010.06.002
Hengstler, 2011, Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A, Crit Rev Toxicol, 41, 263, 10.3109/10408444.2011.558487
Nature Editorial, 2013, Announcement: reducing our irreproducibility, Nature, 496, 398, 10.1038/496398a
Batke, 2013, Relevance of non-guideline studies for risk assessment: the coverage model based on most frequent targets in repeated dose toxicity studies, Toxicol Lett, 218, 293, 10.1016/j.toxlet.2012.09.002
National Research Council, 2014
Bishop, 2014, The use and acceptance of Other Scientifically Relevant Information (OSRI) in the U.S Environmental Protection Agency (EPA) Endocrine Disruptor Screening Program, Birth Defects Res B Dev Reprod Toxicol, 101, 3, 10.1002/bdrb.21077
Silbergeld, 2013, Evidence-based toxicology: strait is the gate, but the road is worth taking, ALTEX, 30, 67, 10.14573/altex.2013.1.067
Birnbaum, 2013, Implementing systematic review at the National Toxicology Program: status and next steps, Environ Health Perspect, 121, A108, 10.1289/ehp.1306711
McCarty, 2012, Information quality in regulatory decision making: peer review versus good laboratory practice, Environ Health Perspect, 120, 927, 10.1289/ehp.1104277
Beronius, 2010, Risk to all or none?. A comparative analysis of controversies in the health risk assessment of Bisphenol A, Reprod Toxicol, 29, 132, 10.1016/j.reprotox.2009.11.007
Scientific Committee on Emerging, 2012
Rooney, 2014, Systematic review and evidence integration for literature-based environmental health science assessment, Environ Health Perspect, 10.1289/ehp.1307972
Woodruff, 2011, An evidence-based medicine methodology to bridge the gap between clinical and environmental health sciences, Health Aff (Millwood), 30, 931, 10.1377/hlthaff.2010.1219
Beronius, 2014, Facilitating the use of non-standard in vivo studies in health risk assessment of chemicals: a proposal to improve evaluation criteria and reporting, J Appl Toxicol, 34, 607, 10.1002/jat.2991
Maxim, 2014, Qualichem in vivo: a tool for assessing the quality of in vivo studies and its application for bisphenol a, PLoS One, 9, e88773, 10.1371/journal.pone.0087738
Hooijmans, 2014, SYRCLE's risk of bias tool for animal studies, BMC Med Res Methodol, 14, 43, 10.1186/1471-2288-14-43
Schneider, 2009, ToxRTool, a new tool to assess the reliability of toxicological data, Toxicol Lett, 189, 138, 10.1016/j.toxlet.2009.05.013
European Chemicals Agency (ECHA), 2011
Vandenberg, 2012, Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses, Endocr Rev, 33, 378, 10.1210/er.2011-1050
Morris, 2012, Reporting standards: rigid guidelines may restrict research, Nature, 491, 192, 10.1038/491192c
Kilkenny, 2010, Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research, PLoS Biol, 8, e1000412, 10.1371/journal.pbio.1000412
Simera, 2010, Transparent and accurate reporting increases reliability, utility, and impact of your research: reporting guidelines and the EQUATOR Network, BMC Med, 8, 24, 10.1186/1741-7015-8-24
Ågerstrand, 2014, Bad reporting or Bad Science? Systematic Data Evaluation as a Means to Improve the Use of Peer-Reviewed Studies in Risk Assessments of Chemicals, Hum Ecol Risk Assessment: Int J, 20, 1427, 10.1080/10807039.2013.854139
Landis, 2012, A call for transparent reporting to optimize the predictive value of preclinical research, Nature, 490, 187, 10.1038/nature11556
Tilson, 2013, Reporting of results from animal studies, Environ Health Perspect, 121, A320, 10.1289/ehp.1307676
US National Research Council of the National Academies, 2011